Survey Shows Declining Trust in Israeli Democracy

A May and November Israel Democracy Institute survey shows a sharp decline in public trust: only about one quarter of Jewish Israelis rate democracy as “good” or “excellent,” Arab Israeli approval has fallen to a historic low of 12%, and trust in most government bodies is between 10% and 41%. The Israel Defense Forces are the major outlier with 81% trust among Jewish respondents; roughly 35% say they could rely on the state in trouble, while 67.5% of Jewish and 76% of Arab Israelis feel no party represents them. Support for Prime Minister Benjamin Netanyahu’s administration sits at about 25% of Jewish Israelis and just over 17% of Arab Israelis amid his three ongoing corruption trials and his declared intent to run again, signaling elevated political and governance risk that could weigh on investor confidence in Israel without indicating an immediate market-moving event.

Analysis

Market structure: Political distrust favours defense and externally‑oriented exporters while penalising domestically exposed banks, real estate and consumer names. Expect flow into listed defense/space contractors (e.g., Elbit Systems, NASDAQ: ESLT) and a relative hit to the broad Israel ETF (iShares MSCI Israel, EIS) as domestic revenue and deposit confidence compress margins over 3–12 months. FX/bond impact will be visible first: lower trust → capital flight pressure on ILS and +25–100bp move higher in short/intermediate sovereign yields in stressed scenarios.

Risk assessment: Tail risks include mass protests, credit‑rating downgrades or conditionality on US aid producing >150bp shock to 5‑yr yields or >7% drop in EIS inside 1–3 months. Immediate (days) risk = volatility spikes around court rulings/election announcements; short term (3–6 months) = widening spreads, deposit re‑pricing; long term (1–3 years) = structural risk premia that raise borrowing costs by 100–200bp if institutional erosion persists. Hidden dependency: security events or US military/financial support are key mitigants — track US aid language and rating‑agency reviews as primary catalysts.

Trade implications: Favor 6–12 month overweight in ESG‑agnostic defense (ESLT) and export pharma/tech (TEVA) while underweight domestic financials/real‑estate/retail via EIS exposure. Use options: buy 3‑month put spreads on EIS to cap downside cost‑effectively and consider buying USD/ILS upside (short ILS) if ILS depreciates >3% in a week. Reduce sovereign bond duration immediately by ~30% and re‑enter on >50bp selloff.

Contrarian angles: Consensus may overstate permanent capital flight; many Israeli tech exporters earn >60% revenue abroad so a 15–25% overshoot in EIS could create buyable opportunities. Defense may already carry a premium — validate valuations before scaling. Unintended consequence: a political stalemate could increase defense budgets and procurement, benefiting smaller tier‑2 suppliers; screen for sub‑$1bn market‑cap contractors with export lanes.

Key Decisions for Investors

• Establish a 2–3% long position in Elbit Systems (NASDAQ: ESLT) with a 6–12 month horizon as a defensive trade; size at 2% NAV and buy 25% notional protection using 3‑month 10% OTM puts if USD/ILS moves >3% weaker in one week.
• Initiate a defensive hedge: buy a 3‑month put spread on iShares MSCI Israel ETF (EIS) – long 10% OTM put, sell 20% OTM put – sized to 1–2% NAV to cap 10–25% tail downside over the next 90 days.
• Reduce direct exposure to Israeli sovereign and bank debt by ~30% within 30 days; if 5‑yr sovereign yields widen >50bp from current levels, cut exposure to zero and redeploy into global investment‑grade alternatives.
• Implement a pair trade: long TEVA (NYSE: TEVA) 2% NAV, short EIS 2% NAV for 3–6 months to capture exporter resilience vs domestic political risk; unwind if EIS rallies >15% or TEVA underperforms by >10% absolute.